Resolve Biosciences is applying the power of Molecular Cartography™ to enable scientists to gain new insights based on the highest-resolution view of single-cell spatial biology. The platform features the company's proprietary, multiplexed, single-molecule detection technology, which offers full spatial context at subcellular resolution, all in a workflow that preserves the sample tissue. The platform offers unparalleled sensitivity and specificity that helps scientists detect individual transcripts and rare signals to interpret fundamental biology and rapidly advance the understanding of complex biological questions in critical fields such as oncology, neuroscience, and infectious disease. The technology has been under development since 2016 and is currently available through an oversubscribed early access program.


Biotechnology

Research

Resolve Biosciences

Resolve Biosciences' headquarters in Monheim am Rhein, Germany

John Stark

Markus Zumbansen

Axel Heinemann

Dr. Dirk Evers

Marko Labus

Hüseyin T.

Kieren Patel, Ph.D., M.B.A., Esq.

Kieren Patel

Aristotelis Nastos

Christopher Alafi

Laura Furmanski

Peer M. Schatz

Description

People (14)

Axel Heinemann

Peer M. Schatz

Viola Gielen

Moein Ghafoori

Sepideh Rezaei

Ricardo Guerreiro

Astha Gupta

Richa Das, PhD

Markus Zumbansen

Sven Brincker

Andreas Stockter

Jishnu Nair

Samik Bhattacharya

Marko Labus

Jobs